Challenges in the management of juvenile idiopathic arthritis with etanercept

References

• PettyRESouthwoodTRMannersPInternational League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001J Rheumatol200431239039214760812
   PubMed Web of Science ®Google Scholar
• McCannLJWooPBiologic therapies in juvenile idiopathic arthritis: why and for whom?Acta Reumatol Port2007321152617450761
   PubMed Web of Science ®Google Scholar
• RupertoNMurrayKJGerloniVA randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexateArthritis Rheum20045072191220115248217
   PubMed Web of Science ®Google Scholar
• WooPSouthwoodTRPrieurAMRandomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritisArthritis Rheum20004381849185710943876
   PubMed Web of Science ®Google Scholar
• KutukculerNCaglayanSAydogduFStudy of pro-inflammatory (TNF-alpha, IL-1alpha, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parametersClin Rheumatol19981742882929776110
   PubMed Web of Science ®Google Scholar
• LeporeLPennesiMSalettaSPerticarariSPresaniGProdanMStudy of IL-2, IL-6, TNF alpha, IFN gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritisClin Exp Rheumatol19941255615657531125
   PubMed Web of Science ®Google Scholar
• ManggeHKenzianHGallistlSSerum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypesArthritis Rheum19953822112207848311
   PubMed Web of Science ®Google Scholar
• FosterHEMarshallNMyersADunkleyPGriffithsIDOutcome in adults with juvenile idiopathic arthritis: a quality of life studyArthritis Rheum200348376777512632431
   PubMed Web of Science ®Google Scholar
• PackhamJCHallMALong-term follow-up of 246 adults with juvenile idiopathic arthritis: social function, relationships and sexual activityRheumatology (Oxford)200241121440144312468827
   PubMed Web of Science ®Google Scholar
• PackhamJCHallMALong-term follow-up of 246 adults with juvenile idiopathic arthritis: education and employmentRheumatology (Oxford)200241121436143912468826
   PubMed Web of Science ®Google Scholar
• PackhamJCHallMALong-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcomeRheumatology (Oxford)200241121428143512468825
   PubMed Web of Science ®Google Scholar
• PackhamJCHallMAPimmTJLong-term follow-up of 246 adults with juvenile idiopathic arthritis: predictive factors for mood and painRheumatology (Oxford)200241121444144912468828
   PubMed Web of Science ®Google Scholar
• van RossumMAvan SoesbergenRMBoersMLong-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatmentAnn Rheum Dis200766111518152417491099
   PubMed Web of Science ®Google Scholar
• GianniniEHRupertoNRavelliALovellDJFelsonDTMartiniAPreliminary definition of improvement in juvenile arthritisArthritis Rheum1997407120212099214419
   PubMed Web of Science ®Google Scholar
• LovellDJGianniniEHReiffAEtanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.N Engl J Med 16200034211763769
   PubMed Web of Science ®Google Scholar
• LovellDJGianniniEHReiffALong-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trialArthritis Rheum200348121822612528122
   PubMed Web of Science ®Google Scholar
• LovellDJReiffAIlowiteNTSafety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritisArthritis Rheum20085851496150418438876
   PubMed Web of Science ®Google Scholar
• LovellDJReiffAJonesOYLong-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritisArthritis Rheum20065461987199416732547
   PubMed Web of Science ®Google Scholar
• PrinceFHTwiltMTen CateRLong-term follow-up on effectiveness and safety of etanercept in JIA: the Dutch national registerAnn Rheum Dis2008
   Web of Science ®Google Scholar
• RobinsonRFNahataMCHayesJRRennebohmRHigginsGQuality-of-Life Measurements in Juvenile Rheumatoid Arthritis Patients Treated with EtanerceptClin Drug Investig2003238511518
   PubMed Web of Science ®Google Scholar
• NielsenSRupertoNGerloniVPreliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritisClin Exp Rheumatol200826468869218799107
   PubMed Web of Science ®Google Scholar
• TynjalaPLahdennePVahasaloPKautiainenHHonkanenVImpact of anti-TNF treatment on growth in severe juvenile idiopathic arthritisAnn Rheum Dis20066581044104916449314
   PubMed Web of Science ®Google Scholar
• VojvodichPFHansenJBAnderssonUSavendahlLHagelbergSEtanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritisJ Rheumatol200734122481248518050366
   PubMed Web of Science ®Google Scholar
• De BenedettiFPignattiPGerloniVDifferences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritisJ Rheumatol1997247140314099228145
   PubMed Web of Science ®Google Scholar
• JelusicMLukicIKTambic-BukovacLInterleukin-18 as a mediator of systemic juvenile idiopathic arthritisClin Rheumatol20072681332133417597334
   PubMed Web of Science ®Google Scholar
• PascualVAllantazFArceEPunaroMBanchereauJRole of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockadeJ Exp Med200520191479148615851489
   PubMed Web of Science ®Google Scholar
• YokotaSImagawaTMoriMEfficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trialLancet 22200837196179981006
   PubMed Web of Science ®Google Scholar
• HorneffGSchmelingHBiedermannTThe German etanercept registry for treatment of juvenile idiopathic arthritisAnn Rheum Dis200463121638164415115709
   PubMed Web of Science ®Google Scholar
• KimuraYPinhoPWalcoGEtanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritisJ Rheumatol200532593594215868633
   PubMed Web of Science ®Google Scholar
• QuartierPTaupinPBourdeautFEfficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset typeArthritis Rheum20034841093110112687553
   PubMed Web of Science ®Google Scholar
• RussoRAKatsicasMMZelazkoMEtanercept in systemic juvenile idiopathic arthritisClin Exp Rheumatol200220572372612412209
   PubMed Web of Science ®Google Scholar
• TakeiSGrohDBernsteinBShahamBGallagherKReiffASafety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritisJ Rheumatol20012871677168011469478
   PubMed Web of Science ®Google Scholar
• RamananAVSchneiderRMacrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritisJ Rheumatol200330240140312563702
   PubMed Web of Science ®Google Scholar
• MakayBYilmazSTurkyilmazZUnalNOrenHUnsalEEtanercept for therapy-resistant macrophage activation syndromePediatr Blood Cancer200850241942116900487
   PubMed Web of Science ®Google Scholar
• CalinADijkmansBAEmeryPOutcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitisAnn Rheum Dis200463121594160015345498
   PubMed Web of Science ®Google Scholar
• DavisJCJrVan Der HeijdeDBraunJRecombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trialArthritis Rheum200348113230323614613288
   PubMed Web of Science ®Google Scholar
• HenricksonMReiffAProlonged efficacy of etanercept in refractory enthesitis-related arthritisJ Rheumatol200431102055206115468375
   PubMed Web of Science ®Google Scholar
• TseSMLaxerRMBabynPSDoriaASRadiologic Improvement of juvenile idiopathic arthritis-enthesitis-related arthritis following anti-tumor necrosis factor-alpha blockade with etanerceptJ Rheumatol20063361186118816755667
   PubMed Web of Science ®Google Scholar
• Arkela-KautiainenMHaapasaariJKautiainenHVilkkumaaIMalkiaELeirisalo-RepoMFavourable social functioning and health related quality of life of patients with JIA in early adulthoodAnn Rheum Dis200564687588015897308
   PubMed Web of Science ®Google Scholar
• MeasePJKivitzAJBurchFXEtanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progressionArthritis Rheum20045072264227215248226
   PubMed Web of Science ®Google Scholar
• HomeffGBurgos-VargasRTNF-alpha antagonists for the treatment of juvenile-onset spondyloarthritidesClin Exp Rheumatol2002206 Suppl 28S137S14212463465
   PubMed Web of Science ®Google Scholar
• KotaniemiKKautiainenHKarmaAAhoKOccurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective studyOphthalmology2001108112071207511713082
   PubMed Web of Science ®Google Scholar
• SmithJAThompsonDJWhitcupSMA randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritisArthritis Rheum2005531182315696578
   PubMed Web of Science ®Google Scholar
• SchmelingHHorneffGEtanercept and uveitis in patients with juvenile idiopathic arthritisRheumatology (Oxford)20054481008101115855187
   PubMed Web of Science ®Google Scholar
• ReiffATakeiSSadeghiSEtanercept therapy in children with treatment-resistant uveitisArthritis Rheum20014461411141511407702
   PubMed Web of Science ®Google Scholar
• TynjalaPLindahlPHonkanenVLahdennePKotaniemiKInfliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritisAnn Rheum Dis200766454855017068061
   PubMed Web of Science ®Google Scholar
• FoeldvariINielsenSKummerle-DeschnerJTumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational surveyJ Rheumatol20073451146115017343318
   PubMed Web of Science ®Google Scholar
• TzaribachevNKuemmerle-DeschnerJEichnerMHorneffGSafety and efficacy of etanercept in children with juvenile idiopathic arthritis below the age of 4 yearsRheumatol Int200828101031103418369626
   PubMed Web of Science ®Google Scholar
• HyrichKLSymmonsDPWatsonKDSilmanAJComparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics RegisterArthritis Rheum20065461786179416736520
   PubMed Web of Science ®Google Scholar
• van der HeijdeDKlareskogLRodriguez-ValverdeVComparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trialArthritis Rheum20065441063107416572441
   PubMed Web of Science ®Google Scholar
• SchmelingHMathonyKJohnVKeysserGBurdachSHorneffGA combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot studyAnn Rheum Dis200160441041211247875
   PubMed Web of Science ®Google Scholar
• HorneffGDe BockFFoeldvariISafety and efficacy of combination of Etanercept and Methotrexate compared to treatment with Etanercept only in patients with juvenile idiopathic arthritis (JIA). Preliminary data from the German JIA RegistryAnn Rheum Dis2008Apr 15 [Epub ahead of print]
   Web of Science ®Google Scholar
• Kuemmerle-DeschnerJBHorneffGSafety and efficacy of once-weekly application of Etanercept in children with juvenile idiopathic arthritisRheumatol Int200728215315617641897
   PubMed Web of Science ®Google Scholar
• PrinceFHTwiltMJansen-WijngaardenNCvan Suijlekom-SmitLWEffectiveness of a once weekly double dose of etanercept in patients with juvenile idiopathic arthritis: a clinical studyAnn Rheum Dis200766570470517324973
   PubMed Web of Science ®Google Scholar
• YimDSZhouHBuckwalterMNestorovIPeckCCLeeHPopulation pharmacokinetic analysis and simulation of the time-concentration profile of etanercept in pediatric patients with juvenile rheumatoid arthritisJ Clin Pharmacol200545324625615703360
   PubMed Web of Science ®Google Scholar
• ZeltserRValleLTanckCHolystMMRitchlinCGaspariAAClinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion proteinArch Dermatol2001137789389911453808
   PubMed Web of Science ®Google Scholar
• WinthropKLRisk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factorNat Clin Pract Rheumatol200621160261017075599
   PubMedGoogle Scholar
• GerloniVPontikakiIGattinaraMFantiniFFocus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patientsAnn Rheum Dis20086781145115217981916
   PubMed Web of Science ®Google Scholar
• DixonWGHyrichKWatsonKLuntMThe influence of anti-TNF therapy upon the incidence and severity of serious lower respiratory tract infections in patients with Rheumatoid Arthritis: results from the BSR biologics registry (BSRBR)Rheumatology200847suppl2ii47
   Google Scholar
• Bout-TabakuSRivas-ChaconRRestrepoRSystemic lupus erythematosus in a patient treated with etanercept for polyarticular juvenile rheumatoid arthritisJ Rheumatol200734122503250418061971
   PubMed Web of Science ®Google Scholar
• Kanakoudi-TsakalidouFTzimouliVPratsidou-GertsiPChronopoulouETrachanaMThe significance of persistent newly developed autoantibodies in JIA patients under long-term anti-TNF treatmentCytokine200842329329718445529
   PubMed Web of Science ®Google Scholar
• MohanNEdwardsETCuppsTRDemyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritidesArthritis Rheum200144122862286911762947
   PubMed Web of Science ®Google Scholar
• LeporeLMarchettiFFacchiniSLeoneVVenturaADrug-induced systemic lupus erythematosus associated with etanercept therapy in a child with juvenile idiopathic arthritisClin Exp Rheumatol200321227627712747299
   PubMed Web of Science ®Google Scholar
• Ramos-CasalsMBrito-ZeronPMunozSAutoimmune diseases induced by TNF-targeted therapies: analysis of 233 casesMedicine (Baltimore)200786424225117632266
   PubMed Web of Science ®Google Scholar
• BloomBJDevelopment of diabetes mellitus during etanercept therapy in a child with systemic-onset juvenile rheumatoid arthritisArthritis Rheum200043112606260811083287
   PubMed Web of Science ®Google Scholar
• van den BrandeJHommesDWPeppelenboschMPInfliximab induced T lymphocyte apoptosis in Crohn’s diseaseJ Rheumatol Suppl200574263015742461
   PubMedGoogle Scholar
• RuemmeleFMPrieurAMTalbotecCGouletOSchmitzJDevelopment of Crohn disease during anti-TNF-alpha therapy in a child with juvenile idiopathic arthritisJ Pediatr Gastroenterol Nutr200439220320615269630
   PubMed Web of Science ®Google Scholar
• MeyboomRHStarKBateJSavageREdwardsIRTNF-alpha inhibitors and leukaemia: international pharmacovigilance reportsDrug Saf200831544544718422389
   PubMed Web of Science ®Google Scholar
• WolfeFMichaudKThe effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observationArthritis Rheum20075651433143917469100
   PubMed Web of Science ®Google Scholar
• SariIBinicierOBirlikMThymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapyRheumatol Int2008
   Web of Science ®Google Scholar
• HaraouiBDifferentiating the efficacy of tumor necrosis factor inhibitorsJ Rheumatol Suppl2005743715742457
   PubMedGoogle Scholar
• YilmazMKendirliSGAltintasDBingolGAntmenBCytokine levels in serum of patients with juvenile rheumatoid arthritisClin Rheumatol2001201303511254238
   PubMed Web of Science ®Google Scholar
• ReiffAThe use of anakinra in juvenile arthritisCurr Rheumatol Rep20057643444016303102
   PubMedGoogle Scholar
• TynjalaPVahasaloPHonkanenVLahdennePDrug survival of the first and second course of anti-TNF agents in juvenile idiopathic arthritisAnn Rheum Dis2008May 8 [Epub ahead of print]
   Google Scholar
• RupertoNLovellDJQuartierPAbatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trialLancet2008372963638339118632147
   PubMed Web of Science ®Google Scholar
• PrinceFHMTwiltMSimonSCMWhen and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritisPediatric Rheumatology20086 Suppl 1P40
   Google Scholar
• HaapasaariJKautiainenHHannulaSPohjankoskiHHakalaMGood results from combining etanercept to prevailing DMARD therapy in refractory juvenile idiopathic arthritisClin Exp Rheumatol200220686787012508784
   PubMedGoogle Scholar
• KietzDAPepmuellerPHMooreTLTherapeutic use of etanercept in polyarticular course juvenile idiopathic arthritis over a two year periodAnn Rheum Dis200261217117311796406
   PubMed Web of Science ®Google Scholar
• LahdennePVahasaloPHonkanenVInfliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label studyAnn Rheum Dis200362324524712594111
   PubMed Web of Science ®Google Scholar